Skip to search.
 FTSE 100 Up 0.21%

Becton, Dickinson and Company (BDX)

-NYSE
135.25 Down 2.66(1.93%) 5 Feb 21:01
|After Hours: : 135.25 0.00 (0.00%) 5 Feb 22:19
Prev Close:137.91
Open:137.50
Bid:131.10 x 300
Ask:137.50 x 200
1y Target Est:164.97
Beta:1.12081
Earnings Date:5 May - 9 May (Est.)
Day's Range:134.71 - 137.95
52wk Range:128.87 - 157.50
Volume:1,227,482
Avg Vol (3m):1,152,520
Market Cap:28.65b
P/E (ttm):41.74
EPS (ttm):3.24
Div & Yield:2.64 (1.95%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BDX at this time.

Comparison

Symbol% ChgMkt Cap
BDXDown 1.93%28.65b
BAXDown 2.09%20.51b
ABTDown 1.58%55.81b

Key Statistics

Forward P/E (1 yr):14.43
P/S (ttm):2.59
Ex-Dividend Date:08-Mar-16

Analysts

Annual EPS Est (Sep-16) :8.41
Quarterly EPS Est (Mar-16) :2.02
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.21

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback